Document is current

Article History

Received: 11 June 2024

Accepted: 21 January 2025

First Online: 13 February 2025

Disclosure

: Judy C. Boughey reports an institutional research grant from Eli Lilly and SimBioSys; royalties from UpToDate; honoraria from EndoMag, PER, PeerView and OncLive; and travel support from EndoMag and Alliance for Clinical Trials in Oncology. She is a member of the Data Safety and Monitoring Committee for Cairns Surgical; serves on the Board of Directors for ASBS; and is an unpaid working group Chair at the Society of Surgical Oncology (SSO) Breast Disease Site. Chantal R. Reyna reports consulting fees from Elucent, honoraria for visiting professor grand rounds, and honoraria from the Japanese Team Science Oncology Program for a facilitator and leadership role for the Association of Women Surgeons Secretary. Marie C. Lee reports an institutional research grant and honoraria from Elucent Medical; participation on the Provepharm Advisory Board; and owns stock in J&J. Mehra Golshan reports funding from the Breast Cancer Research Foundation. Candice A.M. Sauder serves on the Executive Committee of the American Joint Committee on Cancer (AJCC). Cindy B. Matsen reports receiving personal research grants from the Utah Cancer Action Network (Principal Investigator [PI]), Department of Defense (co-Investigator [co-I]), and the National Institutes of Health (NIH; co-I); institutional research funding from the Department of Defense; honoraria from Memorial Sloan Kettering Cancer Center Breast Surgical Oncology Fellows; US patent no. US8207142B2; participation on the Data Safety Monitoring Board for the trial of a patient education tool for an NIH-funded trial; participation on the Ethics Committee of the American Society of Breast Surgeons; and was the SSO representative for the American Society for Radiation Oncology Guidelines Working Group. Christina Yau reports an institutional research grant from the National Cancer Institute (NCI)/NIH; salary and travel support from Quantum Leap Healthcare Collaborative; University of California Inventor Share; and the patent ‘Breast Cancer Response Prediction Subtypes’ (No. 18/174,491). Laura Esserman reports institutional research funding from Moderna for a DCIS trial; publishing royalties from UpToDate; and travel support from and participation on the Medical Advisory Board at Blue Cross Blue Shield. Rita A. Mukhtar reports research support and honoraria from GE Healthcare and the NCI; institutional research funding from the University of California San Francisco; and is an unpaid member of the Scientific Advisory Board for the Lobular Breast Cancer Alliance. Hongmei Yu, Kayla Switalla, Ladores Velle, Alex Lopes, Anne M. Wallace, Rachel B. Lancaster, Todd M. Tuttle, Nora Jaskowiak, Julia Tchou, Roshni Rao, Arpana M. Naik, and Cletus A. Arciero did not report any disclosures that may be relevant to the contents of this study.